ICH Control Group Guidance Fails To Harmonize Requirements - AstraZeneca

The International Conference on Harmonization's clinical trial control groups guidance should offer more specific advice on how to select a control group acceptable to all ICH regulators, AstraZeneca said in recent comments to FDA.

More from Archive

More from Pink Sheet